About Mark Kavulich
Form D filings for Pharmaceutics International from 2022 to 2024 list Mark Kavulich as director.
Mark Kavulich first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Mark Kavulich in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Mark Kavulich works with at each company, as listed on that company's latest Form D.
Pharmaceutics International, Inc. · Form D/A, Oct 23, 2024
DS
David Solomon
Director
SD
Syed Abidi, Ph.D.
Director
JF
John Fowler
Executive officer and director
MB
Michael Bogda
Director
JG
James Gale
Director